G-quadruplex DNA: a novel target for drug design

Area of Science:

• Molecular Biology
• Genetics
• Drug Discovery

Background:

• G-quadruplex (G4) DNA, a non-canonical DNA structure, is increasingly recognized for its roles in cellular processes and disease.
• Evidence confirms G4 DNA's presence in vivo and its involvement in cancer, aging, and neurological disorders.

Purpose of the Study:

• To provide a comprehensive overview of G-quadruplex DNA.
• To highlight G4 structure, detection methods, and functions in physiological and pathological processes.
• To review G4-targeting ligands and their therapeutic potential, as well as G4 unfolding mechanisms.

Main Methods:

• Literature review of G-quadruplex DNA research.
• Summary of G4 detection techniques and structural variations.
• Analysis of G4 functions in gene regulation, DNA replication, and telomere maintenance.
• Review of G4-specific ligands and DNA helicases.

Main Results:

• G4 DNA structures are involved in regulating key genes (e.g., c-MYC, KRAS) and telomere maintenance.
• Various G4 ligands, including CX-5461, show promise for cancer therapy.
• Specific DNA helicases (e.g., Pif1, FANCJ) are involved in G4 unfolding, impacting genomic stability.

Conclusions:

• G-quadruplex DNA represents a promising target for novel therapeutic strategies in various diseases, particularly cancer.
• Understanding G4 structures, functions, and regulatory mechanisms is crucial for developing effective drug designs.
• Further research into G4 ligands and unfolding mechanisms could lead to advanced treatments for genomic instability-related diseases.